Mechanisms of resistance to HIV infection

Springer Seminars in Immunopathology

Volumn 18, Issue 3, 1997, Pages 323-340

  Paxton, William A ^a   Koup, Richard A ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ARTICLE; CELLULAR IMMUNITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; PRIORITY JOURNAL; VIRUS RESISTANCE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; MALE; RECEPTORS, CCR5; RECEPTORS, CYTOKINE; RECEPTORS, HIV; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 0031041651     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00813501     Document Type: Article

References (111)

1. Aldous MC, Watret KC, Mok JY, Bird AG, Froebel KS (1994) Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin Exp Immunol 97:61
2. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996) CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955
3. Arthur LO, Bess JW Jr, Sowder RC II, Benveniste RE, Mann DL, Chermann JC, Henderson LE (1992) Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935
4. Bagasra O, Farzadegan H, Seshamma T, Oakes JW, Saah A, Pomerantz RJ (1994) Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men. J Acquir Immune Defic Syndr 8:1669
5. Bakshi SS, Tetali S, Abrams EJ, Paul MO, Pahwa SG (1995) Repeatedly positive human immunodeficiency virus type 1 DNA polymerase chain reaction in human immunodeficiency virus-exposed seroreverting infants. Pediatr Infect Dis J 14:658
6. Bhat S, Spitalnik SL, Gonzalez-Scarano F, Silberberg DH (1991) Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci USA 88:7131
7. Borkowsky W, Krasinski K, Cao Y, Ho D, Pollack H, Moore T, Chen SH, Allen M, Tao PT (1994) Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes. J Pediatr 125:345
8. Brettler DB, Somasundaran M, Forsberg AF, Krause E, Sullivan JL (1992) Silent HIV-1 infection: a rare occurence in a high risk heterosexual population. Blood 80:2396
9. Bryson YJ, Pang S, Wei LS, Dickover R, Diagne A, Chen ISY (1995) Clearance of HIV infection in a perinatally infected infant. N Engl J Med 332:833
10. Burchett SK, Kornegay J, Pitt J, Landesman S, Rosenblatt H, Hillyer G, Garcia P, Kalish L, Burns D, Davenney K, Lew J (1996) Assessment of maternal plasma HIV viral load as a correlate of vertical transmission. Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections. (Infectious Diseases Society of America for the Foundation for Retrovirology and Human Health) abstr. no. LB3
11. Busch MP, Operskalski EA, Mosley JW, Lee T-H, Henrard D, Herman S, Sachs DH, Harris M, Huang W, Stram DO (1996) Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. J Infect Dis 174:26
12. Byrne JA, Oldstone MBA (1984) Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol 51:682
13. Cao Y, Qing L, Zhang LQ, Safrit JT, Ho DD (1994) Virological and immunological characterization of long-term survivors of HIV-1 infection N Engl J Med 332:201
14. Celentano DD, Nelson KE, Suprasert S, Eiumtrakul S, Tulvatana S, Kuntolbutra S, Akarasewi P, Matanasarawoot A, Wright NH, Sirisopana N, Theetranont C (1996) Risk factors for HIV-1 seroconversion among young men in northern Thailand. JAMA 275:122
15. Chan W, Rodgers A, Hancock R, Taffs F, Kitchin P, Farrar G, Llew F (1992) Protection in SIV-vaccinated monkeys correlates with anti-HLA class I antibody responses. J Exp Med 176:1203
16. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR (1987) Two types of mouse helper T cell clone. J Exp Med 166:1229
17. Cheynier R, Langlade-Demoyen P, Marescot MR, Blanche S, Blondin G, Wain-Hobson S, Griscelli C, Vilmer E, Plata F (1992) Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol 22:2211
18. Chmiel J, Detels R, Kaslow RA, VanRaden M, Kingsley LA, Brookmeyer R, The Multicenter AIDS Cohort Study Group (1987) Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol 126:568
19. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J (1996) The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135
20. H2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107
21. Clerici M, Berzosky JA, Shearer GM, Tacket CO (1991) Exposure to human immunodeficiency virus type 1-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies. J Infect Dis 164:178
22. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho HN, Nishanian PG, Berzofsky JA, Shearer GM (1992) Cell-mediated immune response to human immunodeficiency virus (HIV) type-1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 165:1012
23. Clerici M, Sison AV, Berzofsky JA, Rakusan TA, Brandt CD, Ellaurie M, Villa M, Colie C, Venzon DJ, Sewver JL, Shearer G (1993) Cellular immune factors associated with mother-to-infant transmission of HIV. J Acquir Immune Defic Syndr 7:1427
24. Clerici M, Clark EA, Polacino P, Axberg I, Kuller L, Casey NI, Morton WR, Shearer GM, Benveniste RE (1994) T cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. J Acquir Immune Defic Syndr 8:1391
25. Clerici M, Levin JM, Kessler HA, Harris A, Berzofsky JA, Landay AL, Shearer GM (1994) HIV-specific T helper activity in seronegative health care workers exposed to contaminated blood. JAMA 271:42
26. Cloyd MW, Moore BE (1990) Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolates. Virology 174:103
27. + T cells. Science 270:1811
28. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331:1173
29. + T-lymphocytes from two multiply exposed uninfected individuals resist infection with primary NSI isolates of human immunodeficiency virus type 1. J Virol (in press)
30. Coutlee F, Olivier C, Cassol S, Voyuer H, Kessous EA, Saint AP, He Y, Fauvel M (1994) Absence of prolonged immunosilent infection with human immunodeficiency virus in individuals with high-risk behavior. Am J Med 96:42
31. DeGruttola V, Seage GR, Mayer KH, Horsburgh CR (1989) Infectiousness of HIV between male homosexual partners. J Clin Epidemiol 42:849
32. De Maria A, Cirillo C, Moretta L (1994) Occurence of HIV-specific CTL activity in apparently uninfected children born to HIV-1 infected mothers. J Infect Dis 170:1296
33. Deng H, Liu R, Ellmeir W, Choe S, Unutmaz D, Burkhart M, DiMarzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661
34. DelPrete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, Ricci M, Romagnani S (1991) Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 88:346
35. Detels R, Liu Z, Hennessey K, Kan J, Visscher BR, Taylor JMG, Hoover DR, Rinaldo CR, Phair JP, Saah AJ, Giorgi JV (1994) Resistance to HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirology 7:1263
36. Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Stiehm ER, Bryson YJ (1996) Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 275:599
37. Doranz BJ, Rucker J, Yanjie Y, Symth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149
38. Downs AM, De Vicenzi I (1996) Probability of Heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. J Acquir Immune Defic Syndr Hum Retrovirolgoy 11:388
39. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996) HIV-1 entry into CD4 cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667
40. Fang G, Burger H, Crimson R, Tropper P, Nachman S, Mayers D, Weislow O, Moore R, Reyelt C, Hutcheon N, Baker D, Weiser B (1995) Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 92:12100
41. Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872
42. Goedert JJ, Duliege A-M, Amos CI, Felton S, Biggar RJ (1991) High risk of HIV-1 infection for first-born twins. Lancet 338:1471
43. Horuk R (1994) Molecular properties of the chemokine receptor family. Trends Pharmacol Sci 15:159
44. Imagawa D, Detels R (1991) HIV-1 seronegative homosexual men. N Engl J Med 325:1250
45. Imagawa DT, Lee MH, Wolinsky SM, Sano K, Morales F, Kwok S, Sninsky JJ, Nishanian PG, Giorgi J, Fahey JL, Detels R (1989) Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med 320:1458
46. Jehuda-Cohen T, Slade B, Powell J, Villinger F, De B, Folks T, McClure H, Sell K, Ahmed-Ansari A (1990) Polyclonal B cell activation reveals antibodies against HIV-1 in HIV-1 seronegative individuals. Proc Natl Acad Sci USA 87:3972
47. Just J, Louie L, Abrams E, Nicholas SW, Wara D, Stein Z, King MC (1992) Genetic risk factors for perinatally acquired HIV-1 infection. Paediatr Perinat Epidemiol 6:215
48. Kaslow RA, Duquesnoy R, VanRaden M, Kingsley L, Marrari M, Friedman H, Su S, Saah AJ, Detels R, Phair J (1990) A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet 335:927
49. Kelker HC, Seidlin M, Vogler M, Valentine FT (1992) Lymphocytes from some long-term seronegative heterosexual partners of HIV infected individuals proliferate in response to HIV antigens. AIDS Res Human Retroviruses 8:1355
50. Kilpatrick DC, Hague RA, Yap PL, Mok JY (1991) HLA antigen frequencies in children born to HIV-infected mothers. Dis Markers 9:21
51. Kingsley LA, Detels R, Kaslow R, Polk BF, Rinaldo CRJ, Chmiel J, Detre K, Kelsey SF, Odaka N, Ostrow D, VanRaden M, Visscher B (1987) Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Lancet 1:345
52. Klein MR, Keet IP, D'Amaro J, Bende RJ, Hekman A, Mesman B, Koot M, Waal LP de, Coutinho RA, Miedema F (1994) Associations between HLA frequencies and pathogenic features of human immunodeficinecy virus type 1 infection in seroconverters from Amsterdam cohort of homosexual men. J Infect Dis 169:1244
53. Korber BT, Learn G, Mullins JI, Hahn BH, Wolinsky S (1995) Protecting HIV databases. Nature 378:242
54. Koup RA, Ho DD (1991) Immunosilent HIV-1 infection: intrigue continues. J Acquir Immune Defic Syndr 5:1263
55. Koup R, Cao Y, Ho DD, Krogstad PA, Chen ISY, Korber BT, Wolinsky SM, Mullins J, Walker BD, Ammann A, The Ariel Project Cohort Group (1996) Lack of a maternal viral threshold for vertical transmission of HIV-1. Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections. (Infectious Diseases Society of America for the Foundation for Retrovirology and Human Health) abstr. no. LB2
56. Krieger JN, Coombs RW, Collier AC, Ho DD, Ross SO, Zeh JE, Corey L (1995) Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission. J Urol 154:1035
57. Landesman SH, Kalish LA, Burns DN, Minkoff H, Fox HE, Zorrilla C, Garcia P, Fowler MG, Mofenson L, Tuomala R (1996) Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 334:1617
58. Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E (1994) Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest 93:1293
59. Lederman MM, Jackson BJ, Kroner BL, White GCI, Eyster ME, Aledort LM, Hilgartner MW, Kessler CM, Cohen AR, Kiger KP, Goedert JJ (1995) Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophilicas. J Infect Dis 172:228
60. Lehner T, Wang Y, Cranage M, Bergmeier LA, Mitchell E, Tao L, Hall G, Dennis M, Cook N, Brookes R, Klavinskis L, Jones I, Doyle C, Ward R (1996) Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV enevelope and core vaccine in macaques. Nature Med 2:767
61. Levy JA (1993) HIV pathogenesis and long-term survival. J Acquir Immune Defic Syndr 7:1401
62. Levy JA (1993) Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57:183
63. + T cells. Immunol Today 17:217
64. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell (in press)
65. Liuzzi G, Bagnarelli P, Chirianni A, Clementi M, Nappa S, Tullio Cataldo P, Valenza A, Piazza M (1995) Quantitation of HIV-1 genome copy number in semen and saliva. J Acquir Immune Defic Syndr 9:651
66. Lohman BL, Miller CJ, McChesney MB (1995) Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J Immunol 12:5855
67. Ludlam CA, Tucker J, Steel CM, Tedder RS, Cheingsong-Popov R, Weiss RA, McClelland DBL, Philip I, Prescott RJ (1985) HTLV-III infection in seronegative heamophiliacs after transfusion of Factor VIII. Lancet 11:233
68. Lukacher AE, Braciale VL, Braciale TJ (1984) In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 160:814
69. + cell anti-HIV activity: nonlytic suppression of virus replication. J Acquir Immune Defic Syndr Res Hum Retroviruses 8:1039
70. Maggi E, Mazzetti M, Ravina A, Annunziato F, Carli M de, Piccinni MP, Manetti R, Carbonari M, Pesce AM, DelPrete G, Romagnani S (1994) Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and THO cells. Science 265:244
71. Marcus R (1988) Surveillance of health care workers exposed to blood from patients infected with HIV. N Engl J Med 319:1118
72. Mayaux MJ, Blanche S, Rouzioux C, Le Chenadec J, Chambrin V, Firtion G, Allemon MC, Vilmer E, Vigneron NC, Tricoire J (1995) Maternal factors associated with prenatal HIV-1 transmission: the French Cohort Study. J Acquir Immune Defic Synd Hum Retrovirology 8:188
73. McMichael A, Koup R, Ammann A (1996) Transient HIV infection in infants. N Engl J Med 334:801
74. Moses S, Plummer FA, Bradley J, Ndinya-Achola JO, Nagelkerke NJD, Ronald AR (1994) The association between lack of male circumcision and risk for HIV infection: A review of epidemiological data. Sex Transm Dis 21(4):201
75. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348
76. O'Brien TR, Busch MP, Donegan E, Ward JW, Wong L, Samson SM, Perkins HA, Altman R, Stoneburner RL, Holmberg SD (1994) Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J Acquir Immune Defic Syndr Hum Retrovirology 7:705
77. Ometto L, Zanotto C, Maccabruni A, Caselli D, Truscia D, Giaquinto C, Ruga E, Chieco-Bianchi L, De Rossi A (1995) Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. J Acquir Immune Defic Syndr 9:427
78. Pan L-Z, Sheppard HW, Winkelstein W, Levy JA (1991) Lack of detection of HIV in persistently seronegative homosexual men with high or medium risks for infection. J Infect Dis 164:962
79. Paxton WA, Martin SR, Tse D, O'Brien TR, Skumick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, Koup RA (1996) Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med 2:412
80. Pinto LA, Sullivan J, Berzofsky JA, Clerici M, Kessler HA, Landay AL, Shearer GM (1995) Env-specific cytotoxic T lymphocyte responses in HIV-seronegative health care workers occupationally exposed to HIV contaminated body fluids. J Clin Invest 96:867
81. Plourde PJ, Pepin J, Agoki E, Ronald AR, Ombette J, Tyndall M, Cheang M, Ndinya-Achola JO, D'Costa LJ, Plummer FA (1994) Human immunodeficiency virus type 1 seroconversion in women with gential ulcers. J Infect Dis 170:313
82. Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, Gakinya MN, Waiyaki P, Cheang M, Piot P, Ronald AR, Ngugi EN (1991) Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 163:233
83. Prevots DR, Ancelle-Park RA, Neal JJ, Remis RS (1994) The epidemiology of hetersexually acquired HIV infection and AIDS in western industrialized countries. J Acquir Immune Defic Syndr 8:S109
84. Rasheed S, Li Z, Xu D (1995) Human immunodeficiency virus load. Quantitative assessment in semen from seropositive individuals and in spiked seminal plasma. J Reprod Med 40:747
85. Roos MTL, Lange JMA, Goede REY de, Coutinho RA, Schellekens PTA, Miedema F, Tersmette M (1992) Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis 165:427
86. Roques PA, Gras G, Parnet-Mathieu F, Mabondzo AM, Tranchot-Diallo J, Herve F, LasFargues G, Courpotin C, Dormont D (1995) Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. J Acquir Immune Defic Syndr 9:F19
87. Rowland-Jones SL, Nixon DF, Gotch F, Hallam N, Froebel K, Aldhous MC, Ariyoshi K, Kroll JS, McMichael A (1993) HIV-specific cytotoxic T cell activity in an HIV-exposed but uninfected infant. Lancet 341:860
88. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T, Takiguchi M, Schultz T, McMichael A, Whittle H (1995) HIV-specific cytotoxic T cells in HIV-exposed but uninfected Gambian women. Nature Med 1:59
89. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, Bloom BR (1991) Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279
90. Salvato MS, Emau P, Malkovsky M, Schultz KT, Johnson E, Pauza CD (1994) Cellular immune responses in rhesus macaques infected rectally with low dose simian immunodeficiency virus. J Med Primatol 23:125
91. Schwartz RH (1985) T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol 3:237
92. Sethi KK, Omata Y, Schneweis KE (1983) Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes. J Gen Virol 64:443
93. Simonsen JN, Cameron DW, Gakinya MN, Ndinya-Achola JO, D'Costa LJ, Karasira P, Cheang M, Ronald AR, Piot P, Plummer FA (1988) Human immunodeficiency virus infection among men with sexually transmitted diseases. N Engl J Med 319:274
94. Sperling RS, Shapiro DE, Coombs R, Todd J, McSherry G, Connor EM, Balsley J, Group AP0S (1996) Maternal plasma HIV-RNA and the success of zidovudine (ZDV) in the prevention of mother-child-transmission. Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections. (Infectious Diseases Society of America for the Foundation for Retrovirology and Human Health) abstr. no. LB1
95. Spira AI, Ho DD (1995) Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro. J Virol 69:422
96. Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, Ho DD (1996) Cellular targets of infection and route of viral dissemination following an intravaginal inoculation of SIV into rhesus macaques. J Exp Med 183:215
97. Steel CM, Ludlam CA, Beatson D, Peutherer JF, Cuthbert RJ, Simmonds P, Morrison H, Jones M (1988) HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet I:1185
98. Stefano KA, Collman R, Kolson D, Hoxie J, Nathanson N, Gonzalez-Scarano F (1993) Replication of a macrophage-tropic strain of human immunodeficiency virus type 1 (HIV-1) in a hybrid cell line, CEMx174, suggests that cellular accessory molecules are required for HIV-1 entry. J Virol 67:6707
99. Stott J, Kitchin P, Page M, Flanagan B, Taffs L, Chan W, Mills K, Silvera P, Rodgers A (1991) Anti-cell antibody in macaques. Nature 353:393
100. Study, European Collaborative (1991) Risk factors for mother-to-child transmission of HIV-1 Lancet 339:1007
101. Taylor R (1994) Quiet clues to HIV-1 immunity: do some people resist infection? J NIH Res 6:29
102. Vyakaram A, Matear PM, Martin SJ, Wagstaff M (1995) Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus replication in Th0 cells. Immunology 86:85
103. Wainberg MA, Blain N, Fitz-Gibbon L (1987) Differential susceptibility of human lymphocyte cultures to infection by HIV. Clin Exp Immunol 1987:136
104. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563
105. Ward JW, Bush TJ, Perkins HA, Lieb LE, Allen JR, Goldfinger D, Samson SM, Pepkowitz SH, Fernando LP, Holland PV (1989) The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med 321:947
106. Williams LM, Cloyd MW (1991) Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology 184:723
107. Wolinsky SM, Wike CM, Korber BT, Hutto C, Parks WP, Rosenblum LL, Kunstman KJ, Furtado MR, Munoz JL (1992) Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255:1134
108. Yap KL, Ada GL (1978) The recovery of mice from influenza A infection: adoptive transfer of immunity with influenza virus-specific cytotoxic T lymphocytes recognizing a common virion antigen. Scand J Immunol 8:413
109. Zhang LQ, MacKenzie P, Cleland A, Holmes EC, Leigh Brown AJ, Simmonds P (1993) Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol 67:3345
110. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD (1993) Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179
111. Zhu T, Wang N, Carr A, Nam DS, Moor-Jankowski R, Cooper DA, Ho DD (1996) Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol 70:3098